HIV-1 Drug Resistance in Mother–Infant Pairs in Southern Mozambique

This prospective nested cohort (EARTH) study evaluated drug resistance mutations and outcomes among 79 (31 with genetic results) early-treated Mozambican children living with HIV, followed for 50 months. Mortality reached 20.3%. Drug resistance mutations were detected in 58.1% of children and 50.0% of mothers; 30% of pairs shared mutations. No integrase inhibitor resistance was detected, supporting Mozambique's transition to dolutegravir-based regimens.

Authors

Institutions

Publication Details

Journal
The Pediatric Infectious Disease Journal
Published
2026-09-28
DOI
https://doi.org/10.1097/inf.0000000000005426
Primary Topic
HIV/AIDS drug development and treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

HIV-1 Drug Resistance in Mother–Infant Pairs in Southern Mozambique

Tacilta Nhampossa, Sara Domínguez‐Rodríguez, Eleni Nastouli, Nália Ismael et al.
The Pediatric Infectious Disease Journal
HIV/AIDS drug development and treatment
article

HIV-1 Drug Resistance in Mother–Infant Pairs in Southern Mozambique

Tacilta Nhampossa, Sara Domínguez‐Rodríguez, Eleni Nastouli, Nália Ismael, Elisa López‐Varela, Moira J. Spyer, Carlo Giaquinto, Pablo Rojo, Alfredo Tagarro, Matthew Byott, Maria Grazia Lain, Paolo Rossi, Quique Bassat, Denise Naniche, David Torres-Fernández, Sheila Martínez Fernández, Paula Vaz
article en

Abstract

This prospective nested cohort (EARTH) study evaluated drug resistance mutations and outcomes among 79 (31 with genetic results) early-treated Mozambican children living with HIV, followed for 50 months. Mortality reached 20.3%. Drug resistance mutations were detected in 58.1% of children and 50.0% of mothers; 30% of pairs shared mutations. No integrase inhibitor resistance was detected, supporting Mozambique's transition to dolutegravir-based regimens.

The Pediatric Infectious Disease Journal
University of Rome Tor Vergata (IT), Institució Catalana de Recerca i Estudis Avançats (ES), Universidad Complutense de Madrid (ES), Hospital Sant Joan de Déu Barcelona (ES), University College London Hospitals NHS Foundation Trust (GB), University of Padua (IT), Instituto de Salud Carlos III (ES), Fundação Ariel Glaser Contra o SIDA Pediátrico (MZ), Research Institute Hospital 12 de Octubre (ES), PENTA Foundation (IT), Hospital Universitario 12 De Octubre (ES), Centro de Investigación Biomédica en Red (ES), Manhiça Health Research Centre (MZ), Bambino Gesù Children's Hospital (IT), Instituto Nacional de Saúde (MZ), Barcelona Institute for Global Health (ES), Hospital Universitario del Henares (ES), Hospital Universitario Infanta Sofía (ES), Centro de Investigación Biomédica en Red Enfermedades Infecciosas (ES), University College London (GB), Universitat de Barcelona (ES), Universidad Europea de Madrid (ES)
Good health and well-being
Openalex Percentile: Top 12%
HIV/AIDS drug development and treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.